Cargando…

A possible blood plasma biomarker for early-stage Alzheimer’s disease

We sought to identify a usable biomarker from blood samples to characterize early-stage Alzheimer’s disease (AD) patients, in order to facilitate rapid diagnosis, early therapeutic intervention, and monitoring of clinical trials. We compared metabolites from blood plasma in early-stage Alzheimer’s d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banack, Sandra Anne, Stark, Aleksandra C., Cox, Paul Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022864/ https://www.ncbi.nlm.nih.gov/pubmed/35446894 http://dx.doi.org/10.1371/journal.pone.0267407

Ejemplares similares

An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease
por: Banack, Sandra Anne, et al.
Publicado: (2020)

Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease
por: Dallé, Ernest, et al.
Publicado: (2020)

Correction: Banack, S.A. et al. Production of the Neurotoxin BMAA by a Marine Cyanobacterium. Mar. Drugs 2007, 5, 180–196
por: Banack, Sandra Anne, et al.
Publicado: (2010)

Cyanotoxin Analysis of Air Samples from the Great Salt Lake
por: Metcalf, James S., et al.
Publicado: (2023)

A comparison of the efficiency of RNA extraction from extracellular vesicles using the Qiagen RNeasy MinElute versus Enzymax LLC RNA Tini Spin columns and qPCR of miRNA
por: Dunlop, Rachael Anne, et al.
Publicado: (2021)

L1CAM immunocapture generates a unique extracellular vesicle population with a reproducible miRNA fingerprint
por: Dunlop, Rachael Anne, et al.
Publicado: (2023)

Early Stage Glycosylation Biomarkers in Alzheimer’s Disease
por: Regan, Patricia, et al.
Publicado: (2019)

Detection of β-N-methylamino-l-alanine in postmortem olfactory bulbs of Alzheimer’s disease patients using UHPLC-MS/MS: An autopsy case-series study
por: Garamszegi, Susanna P., et al.
Publicado: (2023)

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
por: Perrin, Richard J., et al.
Publicado: (2011)

Blood pressure variability and plasma Alzheimer’s disease biomarkers in older adults
por: Sible, Isabel J., et al.
Publicado: (2022)

Production of the Neurotoxin BMAA by a Marine Cyanobacterium
por: Banack, Sandra Anne, et al.
Publicado: (2007)

Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of l-Serine Causing Protein Misfolding and Aggregation
por: Dunlop, Rachael Anne, et al.
Publicado: (2013)

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
por: Jellinger, Kurt A, et al.
Publicado: (2008)

Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
por: Galasko, Douglas, et al.
Publicado: (2013)

Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018)

Variability in Content of the Anti-AIDS Drug Candidate Prostratin in Samoan Populations of Homalanthus nutans
por: Johnson, Holly E., et al.
Publicado: (2008)

Inflammatory biomarkers in Alzheimer's disease plasma
por: Morgan, Angharad R., et al.
Publicado: (2019)

Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Blood Biomarkers in Alzheimer’s Disease
por: Mandal, Pravat K., et al.
Publicado: (2023)

Novel blood test for early biomarkers of preeclampsia and Alzheimer’s disease
por: Cheng, Shibin, et al.
Publicado: (2021)

Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain
por: Cox, Paul Alan, et al.
Publicado: (2016)

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
por: Brickman, Adam M., et al.
Publicado: (2022)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2020)

Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
por: Whelan, Christopher D., et al.
Publicado: (2019)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects
por: Nagaraj, Siranjeevi, et al.
Publicado: (2017)

Diagnostic Blood Biomarkers in Alzheimer’s Disease
por: Park, Jung Eun, et al.
Publicado: (2022)

Blood SSR1: A Possible Biomarker for Early Prediction of Parkinson’s Disease
por: Zhang, Wen, et al.
Publicado: (2022)

Cyanobacteria Produce N-(2-Aminoethyl)Glycine, a Backbone for Peptide Nucleic Acids Which May Have Been the First Genetic Molecules for Life on Earth
por: Banack, Sandra Anne, et al.
Publicado: (2012)

L-Serine Influences Epigenetic Modifications to Improve Cognition and Behaviors in Growth Hormone-Releasing Hormone Knockout Mice
por: Zhang, Fang, et al.
Publicado: (2022)

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2022)

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
por: Thambisetty, Madhav, et al.
Publicado: (2011)

Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
por: Di Costanzo, Alfonso, et al.
Publicado: (2020)

Blood‐based biomarkers for Alzheimer's disease
por: Leuzy, Antoine, et al.
Publicado: (2021)

Blood-based molecular biomarkers for Alzheimer’s disease
por: Zetterberg, Henrik, et al.
Publicado: (2019)

Microglial Priming and Alzheimer’s Disease: A Possible Role for (Early) Immune Challenges and Epigenetics?
por: Hoeijmakers, Lianne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_25mf184su5eru71663j5mq7o7p